Compile Data Set for Download or QSAR
Report error Found 7 Enz. Inhib. hit(s) for PDB: 6D26
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 0.400nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 0.400nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataKd:  1nMAssay Description:Displacement of [3H]NVP-QAW039 from human DP2 receptor expressed in CHO cell membranes by TopCount scintillation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 1.40nMAssay Description:Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-13 production after 6 to 8 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 2.60nMAssay Description:Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-5 production after 6 to 8 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 2.60nMAssay Description:Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-5 production after 6 to 8 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataKi:  4nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)